# K241106: Ice Cooling IPL Home Use Hair Removal Device (Model (s): T10B, T10C, T15A, T17A, T18A, T14A, T16A, T19A)

- Pathway: 510(k) (Special)
- Applicant: Shenzhen Mlay Intelligent Technology Co.,, Ltd.
- Decided: May 22, 2024 after 30 days
- Product code: OHT (Light Based Over-The-Counter Hair Removal)
- Device class: 2
- Regulation: 21 CFR 878.4810
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 23 generations back to K950019 (1995). 66 ancestors in all.
2 later devices descend from it; 1 cites it directly.
0 of 69 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K240264: Home Use Hair Removal Device (Model (s):T10A, T10B, T10C, T10D, T11A, T15A, T17A, T18A, T14A, T16A, T19A), Shenzhen Mlay Intelligent Technology Co.,, Ltd. (2024) Summary page 5.
- K223618: IPL Hair Removal Device, Model (s): UI06 PN, UI06 PL, UI06 JL, UI06 BR, UI06 DB, UI06 PR, UI06 OG, UI06 RD, Shenzhen Ulike Smart Electronics Co., Ltd. (2023) Summary page 5.
- K221002: IPL Hair Removal Device, Model (s): UI04A, UI04B, UI04C, Shenzhen Ulike Smart Electronics Co., Ltd. (2022) Summary page 5.
- K173813: IPL Hair Removal Device Joy Version, Shen Zhen Cosbeauty Co., Ltd. (2018) Summary page 6.

## Most influential descendants
- K251176: IPL Hair Removal Device (Model (s): T14B, T16B, T19B, T15B, T17C, T18B, T21A, T21B, T21C, T21D, T22A, T22B, T25B, T25C) (2025), 1 descendant of its own
- K253666: IPL Hair Removal Device (Models: T31A, T32A) (2026), 0 descendants of its own

## Indications for use
The Ice Cooling IPL Home Use Hair Removal Device is an over-the-counter device indicated for the removal of unwanted hair such as but not limited to small areas such as underarm and facial hair below the chin line and large areas such as legs. The device is also indicated for the permanent reduction in hair regrowth, defined as the long term, stable reduction in the amount of hair regrowing when measured at 6, 9 and 12 months after the completion of a treatment regime.

Source page: https://510kreport.com/device/K241106
Methodology: https://510kreport.com/methodology